Skip to main content
logo
Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
0.2400
+0.0064 (2.74%)
At close: Sep 18, 2026, 4:00 PM EDT
0.2470
+0.0070 (2.92%)
After-hours: Sep 18, 2026, 7:59 PM EDT

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $1.48M in the quarter ending June 30, 2026, with 504.92% growth. This brings the company's revenue in the last twelve months to $2.50M, up 287.31% year-over-year. In the fiscal year ending March 31, 2026, Vistagen Therapeutics had annual revenue of $1.27M with 161.11% growth.

Revenue (ttm)
$2.50M
Revenue Growth
+287.31%
P/S Ratio
4.26
Revenue / Employee
$61,000
Employees
41
Market Cap
10.65M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.27M783.00K161.11%
Mar 31, 2025486.00K-578.00K-54.32%
Mar 31, 20241.06M1.29M-
Mar 31, 2023-227.00K-1.34M-
Mar 31, 20221.11M19.40K1.78%
Mar 31, 20211.09M--
Mar 31, 2020---
Mar 31, 2019---
Mar 31, 2018---
Mar 31, 20171.25M--
Mar 31, 2016---
Mar 31, 2015---
Mar 31, 2014---
Mar 31, 2013200.40K-1.14M-85.07%
Mar 31, 20121.34M-728.80K-35.19%
Mar 31, 20112.07M--
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---
Dec 31, 2007---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

VTGN News

More News